« Return to News | Awards & Advancement

Brett Davis named Deloitte Health Informatics general manager

Wednesday, July 3, 2013 08:53 AM

Brett J. Davis has been named general manager of Deloitte Health Informatics (DHI), a newly launched business providing advanced analytics services and products to healthcare providers, researchers and medical manufacturers’ managers.

Davis, who recently joined Deloitte Consulting as a principal, will expand DHI's solutions and network of collaborators in helping health organizations reduce costs, improve outcomes and shrink time involved in developing new therapies.

Previously, Davis was senior director of business development for the health sciences global business unit of Oracle, helping launch its healthcare analytics and translational research solution areas. He has also held leadership roles at IBM's healthcare and life sciences business, most recently as a business unit executive for the public and healthcare sectors.

Davis has published white papers and has spoken at conferences and groups, and his commentary has appeared in InformationWeek, Computer World, Advanced Clinical Trials and Health Data Management.

Davis’ board affiliations include the Personalized Medicine Coalition, the Dean's Advisory Board of the Jefferson School of Population Health and the External Advisory Board of the University of Pennsylvania's Center for Bioethics.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.